Another study that compared PCC patients with patients who had COVID-19 but did not present PCC, and patients who had PCC and recovered, showed that ongoing PCC could be characterised by higher circulating IL-1β, IL-6 and TNFα, 8 to 10 months after acute infection (36). This evidence concerns the gene IL1B and COVID-19.